Glucosamine + Chondroitin
Joint support complex for cartilage maintenance and comfort.
By Suplagen Team · Updated
What it is
Glucosamine and chondroitin are structural components of cartilage. Supplementation aims to support joint integrity and reduce discomfort.
How it works
Glucosamine provides building blocks for glycosaminoglycans; chondroitin inhibits cartilage-degrading enzymes and supports water retention in cartilage.
What the evidence says
Moderate evidence for joint comfort in osteoarthritis; most benefit seen in moderate-to-severe cases.
How much to take
The catalog dose is 1,500 mg daily, and 1,500 mg is also the ceiling; this is a fixed-dose supplement rather than a range. Two capsules is typical.
The evidence is moderate for joint comfort in osteoarthritis, with one nuance worth knowing: the landmark GAIT trial saw benefit mainly in moderate-to-severe knee cases, not mild aches.
When and how to take it
With food, split into 2 or 3 doses if you like. Allow 8 to 12 weeks; joint benefits build slowly.
It's usually paired with MSM, and the pair anchors our joint health guide. Shellfish-free glucosamine exists if allergy is a concern.
Who should skip it
Shellfish allergy matters if the glucosamine is shellfish-derived; vegetarian forms avoid it. Interactions: warfarin (moderate) and antidiabetic medications (mild). Pregnancy safety isn't established.
Safety Notes
- Shellfish-free (vegetarian) glucosamine available. Results take 8-12 weeks. GAIT trial showed benefit mainly for moderate-to-severe knee OA.
- Use caution with: shellfish allergy (if shellfish-derived glucosamine).
- warfarin: Chondroitin may enhance anticoagulant effect; monitor INR.
- antidiabetic medications: Glucosamine may affect blood sugar; monitor.
Common questions
How much glucosamine should I take?
1,500 mg daily with food, split across meals if you prefer. That's both the dose and the ceiling.
How long does glucosamine take to work?
8 to 12 weeks of daily use. Judge it at the end of that window, not at week 2.
Does glucosamine work for mild joint pain?
The best data skews toward moderate-to-severe knee osteoarthritis. For mild aches the evidence is thinner, so expectations should match.